We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
+$9.85M
Cap. Flow
+$95.1M
Cap. Flow %
9.1%
Top 10 Hldgs %
50%
Holding
874
New
223
Increased
214
Reduced
73
Closed
220

Top Buys

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$54.9M
2
IMCR icon
Immunocore
IMCR
+$48.2M
3
ARKK icon
ARK Innovation ETF
ARKK
+$41.6M
4
TWTR
Twitter, Inc.
TWTR
+$36.7M
5
RNAM
Avidity Biosciences
RNAM
+$29.2M

Top Sells

Rank Stock Value
1
RLMD icon
Relmada Therapeutics
RLMD
+$23.6M
2
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
+$19M
3
RBAC
RedBall Acquisition Corp.
RBAC
+$12.5M
4
SMFG icon
Sumitomo Mitsui Financial
SMFG
+$12.1M
5
STOK icon
Stoke Therapeutics
STOK
+$11.8M

Sector Composition

Rank Sector Weight
1 Healthcare 34.11%
2 Financials 8.03%
3 Materials 6.97%
4 Technology 3.58%
5 Industrials 3.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LCAA
76
DELISTED
L Catterton Asia Acquisition Corp Class A Ordinary Shares
LCAA
$991K 0.09%
+100,000
New +$986K
GOOGL icon
77
Alphabet (Google) Class A
GOOGL
$4.37T
$985K 0.09%
10,300
-800
-7% -$88.7K
AAPL icon
78
Apple
AAPL
$4.5T
$950K 0.09%
6,877
+1,377
+25% +$216K
LVWR.WS icon
79
LiveWire Group Warrants
LVWR.WS
$6.66M
$931K 0.09%
+2,659,956
New +$991K
FRON
80
DELISTED
Frontier Acquisition Corp. Class A Ordinary Shares
FRON
$927K 0.09%
+93,500
New +$921K
CLDI icon
81
Calidi Biotherapeutics
CLDI
$3.99M
$893K 0.09%
+47
New +$901K
DMYS
82
DELISTED
dMY Technology Group, Inc. VI
DMYS
$880K 0.08%
88,392
– –
DNAB
83
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
$816K 0.08%
83,220
– –
CVS icon
84
CVS Health
CVS
$122B
$812K 0.08%
+8,512
New +$843K
NAPA
85
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
$808K 0.08%
+56,000
New +$1M
SNCE
86
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$751K 0.07%
23,313
-2,042
-8% -$75.7K
TZPS
87
DELISTED
TZP Strategies Acquisition Corp. Class A Ordinary Share
TZPS
$746K 0.07%
+75,000
New +$742K
FTEV
88
DELISTED
FinTech Evolution Acquisition Group
FTEV
$744K 0.07%
+75,000
New +$739K
HIPO icon
89
Hippo Holdings
HIPO
$856M
$732K 0.07%
+39,481
New +$873K
SLGC
90
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$717K 0.07%
247,226
– –
TALKW
91
DELISTED
Talkspace Inc Warrant
TALKW
$686K 0.07%
2,588,198
+2,367,611
+1,073% +$737K
KVSA
92
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
$667K 0.06%
68,101
+101
+0.1% +$990
BAX icon
93
Baxter International
BAX
$14.4B
$634K 0.06%
+26,411
New +$1.59M
DNAD
94
DELISTED
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
$631K 0.06%
64,139
+10,239
+19% +$100K
CANO.WS
95
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$607K 0.06%
+229,983
New +$339K
JPM icon
96
JPMorgan Chase
JPM
$956B
$603K 0.06%
5,775
-500
-8% -$57.4K
EMB icon
97
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
$588K 0.06%
+7,410
New +$633K
BOAC.WS
98
DELISTED
Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BOAC.WS
$578K 0.06%
4,111,021
+1,776,492
+76% +$192K
IPOD.U
99
DELISTED
Social Capital Hedosophia Holdings Corp. IV Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
IPOD.U
$564K 0.05%
+56,394
New +$566K
CRESW
100
DELISTED
Cresud SACIF y A. Warrant
CRESW
$561K 0.05%
1,305,664
+277,240
+27% +$122K
2 3
4
5 6

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q3 2022 Portfolio in Review

As of Q3 2022, Cowen and Company held 874 positions worth $1.05B, up 0.95% from $1.04B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Cowen and Company deployed $95.1M of net new capital in Q3 2022, opening 223 new positions and adding to 214 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 29% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Relmada Therapeutics, an estimated $23.6M trimmed.

  • Cowen and Company's largest Q3 2022 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.
  • Cowen and Company added most to ARK Innovation ETF in Q3 2022, an estimated $41.6M increase.
  • Cowen and Company's biggest Q3 2022 reduction was Relmada Therapeutics, cutting an estimated $23.6M.
  • Cowen and Company fully exited Pershing Square Tontine Holdings, Ltd. in Q3 2022, selling an estimated $19M.
  • Cowen and Company's ten largest holdings make up 50% of its $1.05B portfolio in Q3 2022.
  • Cowen and Company opened 223 new positions and closed 220 in Q3 2022.
  • Cowen and Company's portfolio value rose 0.95% quarter-over-quarter to $1.05B.

Based on Cowen and Company's 13F filing for Q3 2022, filed 14 Nov 2022.